Live Breaking News & Updates on Uc davis institute

Stay informed with the latest breaking news from Uc davis institute on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Uc davis institute and stay connected to the pulse of your community

Advance your cancer research: SelectScience Special Feature


Discover the scientists advancing cancer research on The Scientists' Channel
Hear from cancer research experts such as Dr. Aleksandra Dukic and Dr. Gerhard Bauer on The Scientists' Channel
Limiting glioblastoma invasion in the brain: Dr. Aleksandra Dukic, postdoctoral researcher at the Institute for Cancer Research, Oslo University Hospital, discusses how she is investigating novel gap junction inhibitors for use in sensitizing glioblastoma cells to chemotherapy.
The incubation technology accelerating CAR-T cell therapy development: Dr. Gerhard Bauer, Professor of Hematology and Oncology and Director of the GMP lab at the UC Davis Institute, reveals the secrets to success in his work on the production of CAR-T cells.

Oslo , Norway , Mattia-zampieri , Komal-kumar-javarappa , Gerhard-bauer , Aleksandra-dukic , Santu-saha , Chris-halbrook , Uc-davis-institute , Selectscience-drug-discovery-development-webinar-series , Immunology-research-summit , Oslo-university-hospital

Advance your cancer research: SelectScience Special Feature


Discover the scientists advancing cancer research on The Scientists' Channel
Hear from cancer research experts such as Dr. Aleksandra Dukic and Dr. Gerhard Bauer on The Scientists' Channel
Limiting glioblastoma invasion in the brain: Dr. Aleksandra Dukic, postdoctoral researcher at the Institute for Cancer Research, Oslo University Hospital, discusses how she is investigating novel gap junction inhibitors for use in sensitizing glioblastoma cells to chemotherapy.
The incubation technology accelerating CAR-T cell therapy development: Dr. Gerhard Bauer, Professor of Hematology and Oncology and Director of the GMP lab at the UC Davis Institute, reveals the secrets to success in his work on the production of CAR-T cells.

Oslo , Norway , Mattia-zampieri , Komal-kumar-javarappa , Gerhard-bauer , Aleksandra-dukic , Santu-saha , Chris-halbrook , Uc-davis-institute , Selectscience-drug-discovery-development-webinar-series , Oslo-university-hospital , Institute-for-cancer-research